Hypertension
28 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Cardiovascular Diseases
Narrower: Essential Hypertension 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Baxdrostat for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Bread with added beta-glucans for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CagriSema for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Control for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Endocalyx Pro for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exercise for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exploratory test group for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fixed-Dose Combination Strategy for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-resistance inspiratory muscle strength training for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| IBI3016 for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ime for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inspiratory muscle strength training for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inspiratory muscle training (IMT) for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lorundrostat for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mandibular advancement Device for essential hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mandibular advancement Device for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Orforglipron for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Placebo + Lorundrostat for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Placebo + Orforglipron for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SAL0140 for hypertension | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tai Chi (CHI) for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Test group for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vicadrostat for hypertension | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.